# Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas

> **NCT00002876** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 35 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** cisplatin
- **DRUG:** etoposide

## Key facts

- **NCT ID:** NCT00002876
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-10
- **Primary completion:** 1998-04
- **Final completion:** 2005-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2011-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002876, "Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00002876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*